These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 3997240)

  • 21. Evaluation of DNA colony hybridization and other techniques for detection of virulence in Yersinia species.
    Robins-Browne RM; Miliotis MD; Cianciosi S; Miller VL; Falkow S; Morris JG
    J Clin Microbiol; 1989 Apr; 27(4):644-50. PubMed ID: 2723033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen.
    Roggenkamp A; Geiger AM; Leitritz L; Kessler A; Heesemann J
    Infect Immun; 1997 Feb; 65(2):446-51. PubMed ID: 9009295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune response to Yersinia outer proteins and other Yersinia pestis antigens after experimental plague infection in mice.
    Benner GE; Andrews GP; Byrne WR; Strachan SD; Sample AK; Heath DG; Friedlander AM
    Infect Immun; 1999 Apr; 67(4):1922-8. PubMed ID: 10085037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Yersinia pestis V protein epitopes recognized by CD4 T cells.
    Parent MA; Berggren KN; Mullarky IK; Szaba FM; Kummer LW; Adamovicz JJ; Smiley ST
    Infect Immun; 2005 Apr; 73(4):2197-204. PubMed ID: 15784563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral immunisation with live aroA attenuated Salmonella enterica serovar Typhimurium expressing the Yersinia pestis V antigen protects mice against plague.
    Garmory HS; Griffin KF; Brown KA; Titball RW
    Vaccine; 2003 Jun; 21(21-22):3051-7. PubMed ID: 12798649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization.
    Nakajima R; Motin VL; Brubaker RR
    Infect Immun; 1995 Aug; 63(8):3021-9. PubMed ID: 7622225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The role of the Yersinia plasmid of calcium-dependency in the formation of the plague immunity].
    Byvalov AA; Darmov IV; Marakulin IV; Obrosova AG; Pogorel'skiĭ IP
    Mol Gen Mikrobiol Virusol; 2005; (4):25-9. PubMed ID: 16334222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigenic profiling of yersinia pestis infection in the Wyoming coyote (Canis latrans).
    Vernati G; Edwards WH; Rocke TE; Little SF; Andrews GP
    J Wildl Dis; 2011 Jan; 47(1):21-9. PubMed ID: 21269993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha.
    Nakajima R; Brubaker RR
    Infect Immun; 1993 Jan; 61(1):23-31. PubMed ID: 8418045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunochemistry of Yersinia enterocolitica O3 grown at different temperatures.
    Barber C; Eylan E
    Microbios; 1977; 20(81-82):145-52. PubMed ID: 84327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoblot analysis of human IgM, IgG and IgA responses to plasmid-encoded antigens of Yersinia enterocolitica serovar O3.
    Ståhlberg TH; Granfors K; Toivanen A
    J Med Microbiol; 1987 Sep; 24(2):157-63. PubMed ID: 2443704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of the temperature-inducible outer membrane proteins of yersiniae.
    Bölin I; Portnoy DA; Wolf-Watz H
    Infect Immun; 1985 Apr; 48(1):234-40. PubMed ID: 3980086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of the plague plasminogen activator in Yersinia pseudotuberculosis and Escherichia coli.
    Kutyrev V; Mehigh RJ; Motin VL; Pokrovskaya MS; Smirnov GB; Brubaker RR
    Infect Immun; 1999 Mar; 67(3):1359-67. PubMed ID: 10024583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A heat-modifiable outer membrane protein carries an antigen specific for the species Yersinia enterocolitica and Yersinia pseudotuberculosis.
    Ogasawara M; Kobayashi S; Arai S; Laheji K; Hill JL; Kono DH; Yu DT
    J Immunol; 1985 Aug; 135(2):1430-6. PubMed ID: 2409152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions between Yersinia enterocolitica and the host with special reference to virulence plasmid encoded adhesion and humoral immunity.
    Paerregaard A
    Dan Med Bull; 1992 Apr; 39(2):155-72. PubMed ID: 1611921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Yersinia pseudotuberculosis and Yersinia pestis are more resistant to bactericidal cationic peptides than Yersinia enterocolitica.
    Bengoechea JA; Lindner B; Seydel U; Ramón D; Ignacio M
    Microbiology (Reading); 1998 Jun; 144 ( Pt 6)():1509-1515. PubMed ID: 9639921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Yersinia enterocolitica, a primary model for bacterial invasiveness.
    Cornelis G; Laroche Y; Balligand G; Sory MP; Wauters G
    Rev Infect Dis; 1987; 9(1):64-87. PubMed ID: 3547579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serological crossreactivity between Brucella abortus and Yersinia enterocolitica 0:9 II the use of Yersinia outer proteins for the specific detection of Yersinia enterocolitica infections in ruminants.
    Kittelberger R; Hilbink F; Hansen MF; Ross GP; Joyce MA; Fenwick S; Heesemann J; Wolf-Watz H; Nielsen K
    Vet Microbiol; 1995 Dec; 47(3-4):271-80. PubMed ID: 8748542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A recombinant bivalent fusion protein rVE confers active and passive protection against Yersinia enterocolitica infection in mice.
    Singh AK; Kingston JJ; Murali HS; Batra HV
    Vaccine; 2014 Mar; 32(11):1233-9. PubMed ID: 24486353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of antibodies in the opsonization of Yersinia spp.
    Tertti R; Eerola E; Granfors K; Lahesmaa-Rantala R; Pekkola-Heino K; Toivanen A
    Infect Immun; 1988 May; 56(5):1295-300. PubMed ID: 3281907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.